Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial

Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic: Non-alcoholic fatty liver disease, expanding core content.
    Difference
    0.2%
    Check dated 2025-10-12T15:22:16.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.
    Difference
    2%
    Check dated 2025-10-05T10:40:04.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Version upgraded to v3.1.0 with removal of a topic (Non-alcoholic fatty liver disease) and no other substantive updates.
    Difference
    0.3%
    Check dated 2025-09-28T03:29:06.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Updated the page from v3.0.1 to v3.0.2, indicating a software release update; removed the 'Back to Top' element as part of the UI cleanup.
    Difference
    0.1%
    Check dated 2025-09-13T17:45:48.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated to include information on non-alcoholic fatty liver disease and has been revised to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-06T15:32:54.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, including the addition of specific drug information for Crizanlizumab and firsocostat, while removing several previous location-related terms and genetic information topics.
    Difference
    2%
    Check dated 2025-08-30T12:17:34.000Z thumbnail image

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.